Atlas Trials

Macugen (Pegaptanib Sodium) Alone, Versus Macugen in Combination With PDT (Photodynamic Therapy) With Visudyne (Verteporfin) in Patients With Age-Related Macular Degeneration (AMD)

Clinical trial NCT00134667 · TERMINATED

Trial details

NCT number
NCT00134667
Sponsor
Eyetech Pharmaceuticals
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Age-Related Macular Degeneration
Start date
2005-03-01
Enrollment
360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.